Showing results (421-430 of 474) with videos related to

Sort By:
Pageof 48
Vaccine|November 17, 2019
The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic reviewStephanie L Hughes, Shelly Bolotin, Sumaiya Khan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
The Lancet. Global Health|June 20, 2020
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Mark Jit, Charlotte Warren-Gash, et al.
The Lancet. Global Health|September 16, 2022
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling studyAmy K Winter, Brian Lambert, Daniel Klein, et al.
Vaccine|February 3, 2023
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countriesAbraham M Getaneh, Xiao Li, Zhuxin Mao, et al.
Plos Medicine|July 18, 2024
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling studyGabrielle Bonnet, John Bimba, Chancy Chavula, et al.
Human Vaccines & Immunotherapeutics|August 12, 2015
Modeling the impact of rubella vaccination in VietnamEmilia Vynnycky, Lay Myint Yoshida, Dang Thi Thanh Huyen, et al.
Journal of Medical Internet Research|May 12, 2025
Population-Wide Depression Incidence Forecasting Comparing Autoregressive Integrated Moving Average and Vector Autoregressive Integrated Moving Average to Temporal Fusion Transformers: Longitudinal Observational StudyDeliang Yang, Yiyi Tang, Vivien Kin Yi Chan, et al.
Archives of Disease in Childhood|May 7, 2018
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancerJessica Bate, Stephen Baker, Judith Breuer, et al.
BMJ Global Health|May 15, 2024
Long-term healthcare utilisation, costs and quality of life after invasive group B Streptococcus disease: a cohort study in five low-income and middle-income countriesFarah Seedat, Simon Procter, Ziyaad Dangor, et al.
Pageof 48